{ "items": [ "\n\n
\n \n\n \n \n \n \n OPDC News\n \n \n \n \n Postdoctoral\n \n \n \n \n Publication\n \n \n \n \n Research\n \n \n \n \n Wade-Martins Group News\n \n \n\n \n\n\n
\n \n\n \n28 September 2020
\n \n \n \nA collaborative study led by the OPDC's Dr Nora Bengoa-Vergniory has shown that compounds known as molecular tweezers could become a promising disease modifying therapy for Parkinson\u2019s.
\n \n\n \n \n\n \n\n \n \n \n \n Awards and Honours\n \n \n \n \n Integrative Neuroscience\n \n \n \n \n Molnar Group News\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n24 September 2020
\n \n \n \nProfessor Zolt\u00e1n Moln\u00e1r has been awarded an Einstein Visiting Fellowship to Charit\u00e9 - University Medicine, Berlin. This award sees him join the dynamic Oxford | Berlin collaboration, a strategic research partnership that supports high quality joint research initiatives across all disciplines of its member institutions, of which Neuroscience is a major focus.
\n \n\n \n \n\n \n\n \n \n \n \n Cardiac Theme\n \n \n \n \n Heather Group News\n \n \n \n \n Publication\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n4 September 2020
\n \n \n \nA new paper from the Heather and Tyler groups has uncovered the mechanism responsible for reduced energy in the hearts of patients with type 2 diabetes and revealed a new therapeutic strategy to reverse the energy deficit.
\n \n\n \n \n\n \n\n \n \n \n \n Cell Physiology\n \n \n \n \n Publication\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n1 September 2020
\n \n \n \nCollaborative research from a leading US cancer centre and the Swietach Group has found that Low pH in lymph nodes inhibits effector T cells, while still allowing T cell activation.
\n \n\n \n \n\n \n\n \n \n \n \n OPDC News\n \n \n \n \n Publication\n \n \n \n \n Research\n \n \n \n \n Wade-Martins Group News\n \n \n\n \n\n\n
\n \n\n \n25 August 2020
\n \n \n \nNew results from a collaborative Oxford Parkinson\u2019s Disease Centre and Cardiff University study on the cellular origins of Parkinson's could be key to developing new treatments.
\n \n\n \n \n\n \n\n \n \n \n \n Publication\n \n \n \n \n Research\n \n \n \n \n Vyazovskiy Group News\n \n \n\n \n\n\n
\n \n\n \n13 August 2020
\n \n \n \nTwo new papers from the Vyazovskiy Group and both Oxford University and international collaborators have made important progress in bridging the gap between the local and global levels of sleep regulation.
\n \n\n \n \n\n \n\n \n \n \n \n Publication\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n7 August 2020
\n \n \n \nIn the wake of concern raised about the ethics and risks of performing genetic interventions in macaque monkeys to study models of human neuropsychiatric conditions, Professor Andrew Parker analyses how decision makers evaluate these situations and highlights the ethical consequences if research is not carried out.
\n \n\n \n \n\n \n\n \n \n \n \n Klemm Group News\n \n \n \n \n Publication\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n7 August 2020
\n \n \n \nAssociate Professor Robin Klemm has edited a special issue for Seminars in Cell and Developmental Biology. \u201cThe molecular cell biology, metabolism and physiological functions of lipid droplets\u201d provides an overview of the most recent developments in the field of lipid droplets, which are important storage organelles at the centre of lipid and energy homeostasis. Prof Klemm joined DPAG in June 2020, bringing with him a new field of research for the department, focusing on the molecular basis of lipid metabolism in professional fat storing cells called adipocytes. His research will impact our basic understanding of the cellular basis of fat metabolism and could lead to innovative new therapies to tackle metabolic disorders such as type II diabetes and obesity.
\n \n\n \n \n\n \n\n \n \n \n \n Integrative Neuroscience\n \n \n \n \n Long Read\n \n \n \n \n Molnar Group News\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n29 July 2020
\n \n \n \nAn in-depth look into a collaborative DPAG, Chemistry and Oxford Martin School project pioneering a radical new approach in which the brain is repaired with 3D-printed neural tissues.
\n \n\n \n \n\n \n\n \n \n \n \n Publication\n \n \n \n \n Research\n \n \n \n \n Wilson Group News\n \n \n\n \n\n\n
\n \n\n \n28 July 2020
\n \n \n \nCollaborative Cancer Research UK-funded studies from DPAG and Oncology researchers have uncovered a new mechanism by which cancer cells adapt to the stresses they encounter as they grow and respond to therapies.
\n \n\n \n \n\n \n\n \n \n \n \n EDI News\n \n \n \n \n Outreach\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n28 July 2020
\n \n \n \nBlack In Neuro Week 2020 is dedicated to celebrating black excellence in neuroscience related fields. Daily social media campaigns highlight key issues and amplify the voices of the Black In Neuro community - #NeuroRacism is the focus of Tuesday 28 July. OPDC Career Development Fellow in Neurobiology Dr Dayne Beccano-Kelly has shared his experience as a black professional working in Parkinson's research in a timely article published in Parkinson's Life.
\n \n\n \n \n\n \n\n \n \n \n \n Cell Physiology\n \n \n \n \n Publication\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n20 July 2020
\n \n \n \nDPAG is among the departments receiving funding from the University's research response fund to undertake COVID-19 research. As part of this effort, the Swietach lab has been studying oxygen transport in the blood of COVID-19 patients. The first results of this study are now published in the British Journal of Haematology and could pave the way for new guidelines for treating the virus.
\n \n\n \n \n\n \n\n \n \n \n \n EDI News\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n13 July 2020
\n \n \n \nResearchers from DPAG and the Department of Psychiatry, including Dr Nikita Ved, in collaboration with The India League, are calling British Indians to voice their opinions and be a part of a seminal piece of work.
\n \n\n \n \n\n \n\n \n \n \n \n Publication\n \n \n \n \n Research\n \n \n \n \n Vyazovskiy Group News\n \n \n\n \n\n\n
\n \n\n \n1 July 2020
\n \n \n \nAssociate Professor Vladyslav Vyazovskiy has edited a special issue of Current Opinion of Physiology with Professor A. Jennifer Morton from the University of Cambridge. \u201cPhysiology of Sleep\u201d compiles the latest developments in sleep research around the complex question of \u2018why do we sleep?\u2019
\n \n\n \n \n\n \n\n \n \n \n \n Lakhal-Littleton Group News\n \n \n \n \n Publication\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n18 June 2020
\n \n \n \nA key hormone in the fetal liver has been found for the first time to play a critical role in determining iron endowment in the newborn baby. Up until now, widely held notions made in comparison to how the adult liver controls iron in the body have led to a common focus on how maternal iron status and function of the placenta determines a baby's iron status. A new study from the Lakhal-Littleton group reveals a more autonomous process takes place within the fetus than previously understood.
\n \n\n \n \n\n \n\n \n \n \n \n Cell Physiology\n \n \n \n \n Publication\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n12 June 2020
\n \n \n \nThe destruction of red blood cells known as hemolysis in the newborn baby is very dangerous, but existing clinical methods are not sufficient for rapid diagnosis and can lead to delays early-life care. A new Swietach Group paper has identified a biomarker that could significantly speed up the process.
\n \n\n \n \n\n \n\n \n \n \n \n Awards and Honours\n \n \n \n \n Cell Physiology\n \n \n \n \n EDI News\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n8 June 2020
\n \n \n \nProfessor Anant Parekh is to deliver the Public Lecture at the prestigious annual conference due to be held in Pune, India, in January 2021.
\n \n\n \n \n\n \n\n \n \n \n \n EDI News\n \n \n \n \n General\n \n \n \n \n Research\n \n \n \n \n Stone Group News\n \n \n\n \n\n\n
\n \n\n \n1 June 2020
\n \n \n \nDr Stone has been awarded a Wellcome Trust Henry Dale Fellowship to lead research investigating how lineage history can impact vascular cell fate and function.
\n \n\n \n \n\n \n\n \n \n \n \n Cell Physiology\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n29 May 2020
\n \n \n \nResearchers at the University of Oxford led by DPAG's Professor Peter Robbins are working with clinical collaborators from NHS hospitals to carry out a new clinical drug trial aimed at treating COVID-19, funded by LifeArc. It will test a drug that could raise oxygen levels in the blood in COVID-19 patients in order to improve their chances of recovery. Raising oxygen levels is important in COVID-19, because many patients with the disease die when oxygen levels in their arterial blood fall to levels that are too low to support life.
\n \n\n \n \n\n \n\n \n \n \n \n Cardiac Theme\n \n \n \n \n Herring Group News\n \n \n \n \n Publication\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n26 May 2020
\n \n \n \nDPAG researchers have collaborated on an international study that demonstrates a detailed mechanistic understanding of how the anti-malaria drug, Hydroxychloroquine, combined with antibiotics, can cause adverse cardiac side-effects in COVID-19 patients. This gives weight to US Federal advice against using this combined treatment.
\n \n\n \n \n